US OptionsDetailed Quotes
PFE240726P31500
- 1.42
- -1.06-42.74%
15min DelayClose Jul 25 16:00 ET
1.67High1.42Low
1.67Open2.48Pre Close8 Volume61 Open Interest31.50Strike Price1.26KTurnover179.20%IV0.33%PremiumJul 26, 2024Expiry Date1.32Intrinsic Value100Multiplier1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.6417Delta0.1203Gamma14.87Leverage Ratio-0.6041Theta-0.0007Rho-9.54Eff Leverage0.0065Vega
Pfizer Stock Discussion
PFE us at resistance, 30.70
Earnings soon, stars aligned
above 50 EMA
When PFE turns, it will move hard and fast. a lot of pressure has been built up over the 1.5-year drop.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.
Sneaking on the radar on a red day.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US)$ $iShares Russell 2000 ETF(IWM.US)$ $MarketAxess(MKTX.US)$ $Pfizer(PFE.US)$ $Vanguard Real Estate ETF(VNQ.US)$ $Global Payments(GPN.US)$
loading...
No comment yet